It is given SQ and does not require close monitoring of blood coagulation tests, allowing for outpatient anticoagulation therapy. The risk of heparin-induced thrombocytopenia and osteoporosis is decreased. A commonly used LMWH is Lovenox (enoxaparin), which is given to prevent DVT in knee ...